Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Osamu Wakahama"'
Autor:
Miki Tateyama, Osamu Wakahama, Takuto Miyagishima, Yasuyuki Kunieda, Satoshi Yuki, Takashi Kato, Yuh Sakata, Mineo Kudo, Masahiro Asaka, Takashi Meguro, Yoshito Komatsu, Nozomu Fuse
Publikováno v:
Advances in Therapy. 27:483-492
Irinotecan and S-1, an oral fluoropyrimidine composed of tegafur, gimeracil, and oteracil potassium, have demonstrated antitumor activity against advanced gastric cancer. We performed a phase 1/2 study to determine the recommended dose, antitumor act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a600a130d46dc021b0544c5b5e02128
https://doi.org/10.1007/s12325-010-0037-2
https://doi.org/10.1007/s12325-010-0037-2
Autor:
Shuji Nishikawa, Osamu Wakahama, Michio Nakamura, Atsushi Nagasaka, Akifumi Higuchi, Kencho Miyashita, Tsuyoshi Sasaki, Tomoya Takahashi, Kyoko Takimoto
Publikováno v:
Journal of Medical Virology. 65:52-57
Essential cryoglobulinemia is associated closely with hepatitis C virus (HCV) infection. The mechanism responsible for occurrence of the disease is unclear. The aim of this study was to investigate pathogenetic roles of HCV in cryoglobulinemia. One h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea40ab7c5c8a1da37b09b240a7bd3ef9
https://doi.org/10.1002/jmv.2000
https://doi.org/10.1002/jmv.2000
Publikováno v:
Kanzo. 38:349-354
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab58755f548987cab1db18cc3aad1d42
https://doi.org/10.2957/kanzo.38.349
https://doi.org/10.2957/kanzo.38.349
Autor:
Satoshi Yuuki, Yoshito Komatsu, Miki Tateyama, Osamu Wakahama, Masao Watanabe, Takuto Miyagishima, Masahiro Asaka, Nozomu Fuse, Yasuyuki Kunieda, Takashi Kato, Yu Sakata, Mineo Kudo
Publikováno v:
Clinical drug investigation. 30(4)
Background: Combined therapy with irinotecan/fluorouracil/levoleucovorin (calcium levofolinate) [IFL] has lost its position as the standard regimen for metastatic colorectal cancer because its toxicity and effectiveness have become controversial. Obj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::940b1f34130982ad32d52bdbb6ced394
https://pubmed.ncbi.nlm.nih.gov/20225907
https://pubmed.ncbi.nlm.nih.gov/20225907
Autor:
Satoshi Yuuki, Yu Sakata, Takuto Miyagishima, Yoshito Komatsu, Maso Watanabe, Takashi Kato, Yasuyuki Kunieda, Takashi Meguro, Nozomu Fuse, Masaaki Takei, Hirotoshi Akita, Masahiro Asaka, Hiroko Ohizumi, Miki Tateyama, Osamu Wakahama, Mineo Kudo
Publikováno v:
Japanese Journal of Clinical Oncology. 35:88-89
We have previously reported on phase I/II studies of irinotecan plus S-1 therapy for advanced gastric cancer. Based on the safety and efficacy data that were obtained, this phase II study was planned to assess the efficacy of irinotecan plus S-1 for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eafc6278f47e66e1c96d46ce7365cea0
https://doi.org/10.1093/jjco/hyi025
https://doi.org/10.1093/jjco/hyi025